13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001697013
申报总市值
US$19.3亿
US$19.3亿
65 檔
26.4%
Eversept Partners, LP 在 Q4 2024 季度的美股仓位总计估值为 US$19.3亿，分散于 65 个持仓标的之中，反映其市场参与广度与投资规模。
在 Q4 2024，Eversept Partners, LP 展现出较为审慎的避险与获利了结姿态。本季共减仓 31 个仓位并完全清仓 17 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，Eversept Partners, LP 的前 5 大核心持股（包含 NTRA, QQQ, GSK 等）合计占整体申报市值的 26.4%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NTRA | Natera Inc | 股票-医疗保健 | 12.32% | -1.58% | +0.76% | |
| 2 | QQQ | Invesco Qqq Trust Series 1 | ETF-科技型 | 11.03% | -3.49% | -2.60% | |
| 3 | GSK | Gsk Plc-spon Adr | 股票-医疗保健 | 10.99% | -3.89% | -9.75% | |
| 4 | VERA | Vera Therapeutics Inc | 股票-其他 | 6.01% | +0.32% | -21.96% | |
| 5 | INSP | Inspire Medical Systems Inc | 股票-医疗保健 | 4.84% | — | +6.53% | |
| 6 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 4.68% | +0.01% | +36.20% | |
| 7 | TEVA | Teva Pharmaceutical-sp Adr | 股票-医疗保健 | 4.39% | — | -30.68% | |
| 8 | RVTY | Revvity Inc | 股票-医疗保健 | 3.89% | +0.09% | -16.43% | |
| 9 | HQY | Healthequity Inc | 股票-医疗保健 | 3.29% | -0.23% | EXIT | |
| 10 | ZIMV | Zimvie Inc | 股票-其他 | 2.56% | — | — | |
| 11 | PTGX | Protagonist Therapeutics Inc | 股票-其他 | 2.33% | +0.37% | NEW | |
| 12 | TECH | Bio-techne CORP | 股票-医疗保健 | 1.91% | -0.28% | -54.89% | |
| 13 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.61% | +0.46% | +27.43% | |
| 14 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-大型股与成长 | 1.55% | -3.67% | EXIT | |
| 15 | VTRS | Viatris Inc | 股票-医疗保健 | 1.41% | — | -26.31% | |
| 16 | TLT | Ishares 20+ Year Treasury Bd | ETF-政府公债 | 1.39% | -1.96% | EXIT | |
| 17 | UTHR | United Therapeutics CORP | 股票-医疗保健 | 1.37% | -0.17% | -66.63% | |
| 18 | VRDN | Viridian Therapeutics Inc | 股票-其他 | 1.33% | +0.05% | +12.84% | |
| 19 | BCRX | Biocryst Pharmaceuticals Inc | 股票-其他 | 1.32% | -0.56% | +269.87% | |
| 20 | BRKR | Bruker CORP | 股票-医疗保健 | 1.22% | +0.35% | — | |
| 21 | EW | Edwards Lifesciences CORP | 股票-医疗保健 | 1.12% | — | — | |
| 22 | DXCM | Dexcom Inc | 股票-医疗保健 | 1.03% | — | — | |
| 23 | CNC | Centene CORP | 股票-医疗保健 | 1.01% | -0.19% | EXIT | |
| 24 | TFX | Teleflex Inc | 股票-医疗保健 | 0.98% | — | — | |
| 25 | ELV | Elevance Health Inc | 股票-医疗保健 | 0.96% | — | +49.90% | |
| 26 | PCVX | Vaxcyte Inc | 股票-其他 | 0.93% | -0.93% | — | |
| 27 | TVTX | Travere Therapeutics Inc | 股票-其他 | 0.76% | +1.50% | -43.64% | |
| 28 | CYH | Community Health Systems Inc | 股票-其他 | 0.75% | +0.01% | -67.79% | |
| 29 | GH | Guardant Health Inc | 股票-医疗保健 | 0.75% | — | — | |
| 30 | RGEN | Repligen CORP | 股票-医疗保健 | 0.69% | -0.65% | -66.95% | |
| 31 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 0.67% | +0.23% | -54.40% | |
| 32 | FTRE | Fortrea Holdings Inc | 股票-医疗保健 | 0.67% | — | -12.28% | |
| 33 | NAMS | NewAmsterdam Pharma Company N.V. | 股票-其他 | 0.63% | — | -10.41% | |
| 34 | AZNN | Astrazeneca Plc-spons Adr | 股票-其他 | 0.60% | — | — | |
| 35 | LQDA | Liquidia CORP | 股票-其他 | 0.60% | +0.42% | +314.14% | |
| 36 | MEDP | Medpace Holdings Inc | 股票-医疗保健 | 0.56% | — | — | |
| 37 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 0.54% | +0.22% | — | |
| 38 | MNKD | Mannkind CORP | 股票-其他 | 0.52% | — | -54.28% | |
| 39 | HUM | Humana Inc | 股票-医疗保健 | 0.51% | +0.64% | NEW | |
| 40 | HSIC | Henry Schein Inc | 股票-医疗保健 | 0.49% | — | — | |
| 41 | DHR | Danaher CORP | 股票-医疗保健 | 0.45% | — | -42.21% | |
| 42 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 0.40% | -0.38% | -91.64% | |
| 43 | PDCOEUR | Patterson Cos Inc | 股票-其他 | 0.40% | — | — | |
| 44 | GOSS | Gossamer Bio Inc | 股票-其他 | 0.40% | — | — | |
| 45 | EOLS | Evolus Inc | 股票-其他 | 0.38% | — | -15.45% | |
| 46 | ICLR | ICON Public Limited Company | 股票-医疗保健 | 0.36% | -0.40% | EXIT | |
| 47 | SUPN | Supernus Pharmaceuticals Inc | 股票-医疗保健 | 0.34% | — | — | |
| 48 | AVTR | Avantor Inc | 股票-医疗保健 | 0.31% | -1.23% | EXIT | |
| 49 | PBYI | Puma Biotechnology Inc | 股票-其他 | 0.27% | — | -22.98% | |
| 50 | TSVT* | 2seventy Bio Inc | 股票-其他 | 0.26% | — | +0.56% |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | NTRA | Natera Inc | +4.8% | +0.76% | 加仓 |
| 2 | QQQ | Invesco Qqq Trust Series 1 | +2.7% | -2.60% | 减仓 |
| 3 | HQY | Healthequity Inc | +1.5% | +21.19% | 加仓 |
| 4 | TLT | Ishares 20+ Year Treasury Bd | +1.4% | NEW | 新建仓 |
| 5 | BRKR | Bruker CORP | +1.2% | NEW | 新建仓 |
| 6 | EW | Edwards Lifesciences CORP | +1.1% | NEW | 新建仓 |
| 7 | HCA | Hca Healthcare Inc | +1.1% | +36.20% | 加仓 |
| 8 | BCRX | Biocryst Pharmaceuticals Inc | +1% | +269.87% | 加仓 |
| 9 | DXCM | Dexcom Inc | +1% | NEW | 新建仓 |
| 10 | TFX | Teleflex Inc | +1% | NEW | 新建仓 |
| 11 | PTGX | Protagonist Therapeutics Inc | +1% | +52.47% | 加仓 |
| 12 | PCVX | Vaxcyte Inc | +0.9% | NEW | 新建仓 |
| 13 | INSP | Inspire Medical Systems Inc | +0.9% | +6.53% | 加仓 |
| 14 | GH | Guardant Health Inc | +0.8% | NEW | 新建仓 |
| 15 | AZNN | Astrazeneca Plc-spons Adr | +0.6% | NEW | 新建仓 |
| 16 | MEDP | Medpace Holdings Inc | +0.6% | NEW | 新建仓 |
| 17 | XENE | Xenon Pharmaceuticals Inc | +0.5% | NEW | 新建仓 |
| 18 | LQDA | Liquidia CORP | +0.5% | +314.14% | 加仓 |
| 19 | HSIC | Henry Schein Inc | +0.5% | NEW | 新建仓 |
| 20 | TEVA | Teva Pharmaceutical-sp Adr | +0.4% | -30.68% | 减仓 |
| 21 | PDCOEUR | Patterson Cos Inc | +0.4% | NEW | 新建仓 |
| 22 | SUPN | Supernus Pharmaceuticals Inc | +0.3% | NEW | 新建仓 |
| 23 | ZIMV | Zimvie Inc | +0.3% | — | 不变 |
| 24 | CNC | Centene CORP | +0.3% | +39.67% | 加仓 |
| 25 | CLDX | Celldex Therapeutics Inc | +0.3% | +27.43% | 加仓 |
| 26 | NAMS | NewAmsterdam Pharma Company N.V. | +0.3% | -10.41% | 减仓 |
| 27 | ELV | Elevance Health Inc | +0.3% | +49.90% | 加仓 |
| 28 | VRDN | Viridian Therapeutics Inc | +0.3% | +12.84% | 加仓 |
| 29 | XRAY | Dentsply Sirona Inc | +0.2% | NEW | 新建仓 |
| 30 | 2662247D | Iteos Therapeutics Inc | +0.2% | NEW | 新建仓 |
| 31 | ICLR | ICON Public Limited Company | +0.1% | +40.85% | 加仓 |
| 32 | GOSS | Gossamer Bio Inc | +0.1% | — | 不变 |
| 33 | XOMA | Xoma Royalty Corporation | +0.1% | +1.20% | 加仓 |
| 34 | VTRS | Viatris Inc | 0% | -26.31% | 减仓 |
| 35 | FTRE | Fortrea Holdings Inc | 0% | -12.28% | 减仓 |
| 36 | PBYI | Puma Biotechnology Inc | 0% | -22.98% | 减仓 |
| 37 | ZLAB | Zai Lab Ltd-adr | 0% | -23.88% | 减仓 |
| 38 | ✓ | Merus N V | 0% | — | 不变 |
| 39 | MREO | Mereo Biopharma Group Pl-adr | 0% | — | 不变 |
| 40 | AVTR | Avantor Inc | 0% | — | 不变 |
| 41 | ABSI | Absci CORP | 0% | -26.90% | 减仓 |
| 42 | ACIU | AC Immune SA | 0% | EXIT | 清仓 |
| 43 | STOK | Stoke Therapeutics Inc | 0% | EXIT | 清仓 |
| 44 | ✓ | Affimed N V | 0% | EXIT | 清仓 |
| 45 | TSVT* | 2seventy Bio Inc | -0.1% | +0.56% | 加仓 |
| 46 | IFRX | InflaRx N.V. | -0.1% | -69.64% | 减仓 |
| 47 | TVTX | Travere Therapeutics Inc | -0.1% | -43.64% | 减仓 |
| 48 | ✓ | Amarin Corp PLC | -0.1% | -54.17% | 减仓 |
| 49 | ✓ | -0.1% | EXIT | 清仓 | |
| 50 | AUTL | Autolus Therapeutics PLC | -0.1% | -75.68% | 减仓 |
根据 SEC 官方 Form 13F 申报备案，Eversept Partners, LP 在 Q4 2024 季度的美股持仓总市值约为 US$19.3亿，共申报了 65 个公开持股仓位。
在 Q4 2024 季度，Eversept Partners, LP 按市值排列的前三大核心持股分别为：NTRA (12.3%)、QQQ (11.0%)、GSK (11.0%)。其中最大持股仓位 NTRA 占据整体投资组合约 12.3% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
TLT
市值: US$1566.7万
本季最大获利了结 / 清仓标的
INSM
前期市值: US$7952.6万
在 Q4 2024 季度中，Eversept Partners, LP 共进行了 77 项持仓异动，包含新建仓 15 个仓位、加仓 14 个仓位、减仓 31 个仓位以及清仓 17 个仓位。 其中最大新建仓标的为 TLT。 本季清仓仓位包含 INSM。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。